Status:
UNKNOWN
Neurophysiologic Assessment of ET Patients Treated by Vim DBS
Lead Sponsor:
University College London Hospitals
Conditions:
Essential Tremor
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Essential tremor is a chronic and progressive neurological disease characterized by upper limb tremor. This is one of the most frequent movement disorders. Most of the time the disease worsens over th...
Detailed Description
Essential tremor (ET) is a chronic, progressive neurological disease characterized by a symmetrical 4-12 Hz kinetic tremor constantly affecting hands and arms. The tremor can also involve the neck, th...
Eligibility Criteria
Inclusion
- Age \> 18 years
- No gender specification
- Patient suffering from severe medically intractable essential tremor and treated by Vim-DBS
- Willing and able to provide written informed consent
Exclusion
- Concurrent and/or recent involvement in other research that is likely to interfere with the intervention within the last 3 months before study enrolment
- Patients presenting with other cause(s) of balance or gait disorders (stroke, concomitant neurological, rheumatological or orthopaedic disease, severe hypopallesthesia, visual impairment, neuromuscular or vestibular disorders)
- Recently implanted patients (\<3 months)
- Patients unable to provide written informed consent (patients presenting with psychiatric or cognitive disorders)
Key Trial Info
Start Date :
May 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05362448
Start Date
May 23 2022
End Date
November 1 2022
Last Update
May 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Hospital for Neurology and Neurosurgery
London, England, United Kingdom, WC1N 3BG